These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 11750440

  • 21. Effects of angiotensin II receptor blocker on proteinuria in renal transplant recipients.
    Tanji N, Ohoka H, Shimamoto K, Ikeda T, Miyauchi Y, Yokoyama M.
    In Vivo; 2004; 18(4):433-6. PubMed ID: 15369180
    [Abstract] [Full Text] [Related]

  • 22. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
    Montanaro D, Gropuzzo M, Tulissi P, Vallone C, Boscutti G, Mioni R, Risaliti A, Baccarani U, Adani GL, Sainz M, Bresadola F, Mioni G.
    Transplant Proc; 2005 Mar; 37(2):991-3. PubMed ID: 15848600
    [Abstract] [Full Text] [Related]

  • 23. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC, El Aouar LM, Mill JG.
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [Abstract] [Full Text] [Related]

  • 24. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 25. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
    Schmidt A, Gruber U, Böhmig G, Köller E, Mayer G.
    Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of enalapril in the treatment of erythrocytosis in patients with renal allografts.
    Carvalho MF, Balbi AL, Corrêa LA, Soares VA.
    Transplant Proc; 1996 Dec; 28(6):3377. PubMed ID: 8962316
    [No Abstract] [Full Text] [Related]

  • 27. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP, Sareli P, Marin F, Aroca-Martinez G, Maritz FJ, Jardim PC, Guerrero AA, Thompson CA, Bero T, Drazka J, Kosmalova V, Dumortier T, Smith RD.
    Adv Ther; 1999 Dec; 16(5):187-99. PubMed ID: 10915394
    [Abstract] [Full Text] [Related]

  • 28. Losartan and renal transplantation.
    Horn S, Holzer H, Horina J.
    Lancet; 1998 Jan 10; 351(9096):111. PubMed ID: 9439500
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of Effect of Enalapril and Losartan Monotherapy on Quality of Life and Safety of Stage 1 Hypertensive Patients.
    Maharshi V, Rehan HS, Gupta LK, Yadav M.
    Indian J Physiol Pharmacol; 2016 Apr 10; 60(2):174-181. PubMed ID: 29809375
    [Abstract] [Full Text] [Related]

  • 30. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M, Tylicki L, Rutkowski P, Rutkowski B.
    Scand J Urol Nephrol; 2004 Apr 10; 38(5):427-33. PubMed ID: 15764256
    [Abstract] [Full Text] [Related]

  • 31. Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study.
    Iñigo P, Campistol JM, Saracho R, Del Castillo D, Anaya F, Esforzado N, Navarro MD, Oppenheimer F.
    Nephron Clin Pract; 2003 Apr 10; 95(3):c84-90. PubMed ID: 14646368
    [Abstract] [Full Text] [Related]

  • 32. Comparison of enalapril and losartan in the treatment of posttransplant erythrocytosis.
    Celik A, Ok E, Unsal A, Töz H, Atabay G.
    Nephron; 2000 Nov 10; 86(3):394-5. PubMed ID: 11096321
    [No Abstract] [Full Text] [Related]

  • 33. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep 10; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 34. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
    Nakache R, Weinbroum A, Merhav H, Katz P, Kaplan E.
    Transplant Proc; 2001 May 10; 33(3):2294-5. PubMed ID: 11377533
    [No Abstract] [Full Text] [Related]

  • 35. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul 10; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
    Pollock DM, Divish BJ, Polakowski JS, Opgenorth TJ.
    J Pharmacol Exp Ther; 1993 Nov 10; 267(2):657-63. PubMed ID: 8246138
    [Abstract] [Full Text] [Related]

  • 37. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
    Mackie FE, Meyer TW, Campbell DJ.
    Kidney Int; 2002 Feb 10; 61(2):555-63. PubMed ID: 11849396
    [Abstract] [Full Text] [Related]

  • 38. A comparative study of losartan and enalapril on erythropoiesis and renal function in hypertensive patients with renal parenchymal disease.
    Shand BI, Lynn KL.
    Clin Nephrol; 2000 Nov 10; 54(5):427-8. PubMed ID: 11105808
    [No Abstract] [Full Text] [Related]

  • 39. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Konno Y, Tsuruga K, Ito E, Waga S.
    Pediatr Int; 2004 Oct 10; 46(5):576-9. PubMed ID: 15491387
    [Abstract] [Full Text] [Related]

  • 40. Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis.
    Iñigo P, Torregrosa JV, Campistol JM, Oppenheimer F.
    Transplant Proc; 1999 Sep 10; 31(6):2321. PubMed ID: 10500598
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.